About: The Use Biochemical Markers in Cardiotoxicity Monitoring in Patients Treated for Leukemia     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • Cílem této studie bylo monitorování kardiotoxicity indukční chemoterapie u pacientů s akutní meloidní leukémií (AML) a zhodnocení potenciálu biochemických markerů v časné diagnostice kardiotoxicity. Ve studii bylo 15 pacientů s nově diagnostikovanou AML, kteří dostali Idarubicin (IDA) 3x12 mg/m2 a střední dávky Cytarabinu (8x1,5 g/m2). Hodnoty NT-proBNP byly změřeny na počátku, den po IDA infuzi, po 14 dnech a 1 měsíci. Naše výsledky naznačují, že indukční terapie in AML nezpůsobuje detekovatelné poškození struktury myocytů a u všech pacientů je spojena s neurohumorální aktivací což je známkou akutní subklinické kardiotoxicity. Tato terapie může vést k městnavému srdečnímu selhání a NT-proBNP se zdá být slibným časným markerem a predikátorem této komplikace. (cs)
  • The aim of the study was to monitor cardiotoxicity of induction chemotherapy in acute myeloid leukemia (AML) patients and to assess the potential for use of biochemical markers in early diagnostics of cardiotoxicity. Our results suggest that induction chemotherapy in AML (IDA 36 mg/m2 and intermediate doses of Cytarabine): 1. does not cause detectable damage of the myocyte structure, 2. is in all patients associated with acute neurohumoral activation (transient elevation of NT-proBNP) indicating acute subclinical cardiotoxicity, 3. may lead to congestive heart failure and NT-proBNP seems to be a promising early marker and predictor of this complication.
  • The aim of the study was to monitor cardiotoxicity of induction chemotherapy in acute myeloid leukemia (AML) patients and to assess the potential for use of biochemical markers in early diagnostics of cardiotoxicity. Our results suggest that induction chemotherapy in AML (IDA 36 mg/m2 and intermediate doses of Cytarabine): 1. does not cause detectable damage of the myocyte structure, 2. is in all patients associated with acute neurohumoral activation (transient elevation of NT-proBNP) indicating acute subclinical cardiotoxicity, 3. may lead to congestive heart failure and NT-proBNP seems to be a promising early marker and predictor of this complication. (en)
Title
  • The Use Biochemical Markers in Cardiotoxicity Monitoring in Patients Treated for Leukemia
  • Použití biochemických markerů k monitorování kardiotoxicity terapie u nemocných leukémií (cs)
  • The Use Biochemical Markers in Cardiotoxicity Monitoring in Patients Treated for Leukemia (en)
skos:prefLabel
  • The Use Biochemical Markers in Cardiotoxicity Monitoring in Patients Treated for Leukemia
  • Použití biochemických markerů k monitorování kardiotoxicity terapie u nemocných leukémií (cs)
  • The Use Biochemical Markers in Cardiotoxicity Monitoring in Patients Treated for Leukemia (en)
skos:notation
  • RIV/00216208:11150/05:00004795!RIV08-MSM-11150___
http://linked.open.../vavai/riv/strany
  • 430;433
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • S
http://linked.open...iv/cisloPeriodika
  • 5
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 548040
http://linked.open...ai/riv/idVysledku
  • RIV/00216208:11150/05:00004795
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • Biochemical; Markers; Cardiotoxicity; Monitoring; Patients; Treated; Leukemia (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • SK - Slovenská republika
http://linked.open...ontrolniKodProRIV
  • [296326E26457]
http://linked.open...i/riv/nazevZdroje
  • Neoplasma
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 52
http://linked.open...iv/tvurceVysledku
  • Malý, Jaroslav
  • Pudil, Radek
  • Žák, Pavel
issn
  • 0028-2685
number of pages
http://localhost/t...ganizacniJednotka
  • 11150
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software